|
AIDSinfo
At-a-Glance
Issue No. 35
October
13, 2005
AIDSinfo.nih.gov is
pleased to provide you with a weekly update of highlights about what has
happened in the world of HIV/AIDS treatment, prevention, and research. We
hope you find this encapsulated view of HIV/AIDS news useful.
“Love Yourself,
Protect Yourself, Get Tested for HIV!”
These
words to live by sum up the message of this year’s Third Annual National Latino AIDS Awareness Day
(NLAAD) on
October 15, 2005.
This
Saturday is the day set aside for Latinos to
renew their commitment to ending the spread of HIV and to ensuring quality
of life for those living with HIV. For more information about this
historic event, go to: http://www.cdcnpin.org/scripts/index.asp.
Also, read a statement about NLAAD from Dr. Anthony S. Fauci, Director of
the National Institute of Allergy and Infectious Diseases at: http://www3.niaid.nih.gov/about/directors/news/latvax05.htm
First Phase II Trial
of HIV/AIDS Vaccine Starts
The National Institute of Allergy and
Infectious Diseases (NIAID), part of the National Institutes of Health
(NIH), announced that a new HIV/AIDS vaccine trial has moved into the
second phase of clinical testing. The vaccine is targeted against multiple
HIV subtypes found worldwide.
“This
trial marks an important step in the advancement toward an AIDS vaccine.
The rapid development of this candidate vaccine—less than five years since
the launch of the VRC (Vaccine Research Center)—underscores our commitment
to hasten the day when we have an effective AIDS vaccine,” says NIAID
Director Anthony S. Fauci, M.D.
Read
the full story here: http://www3.niaid.nih.gov/news/newsreleases/2005/globalvax.htm
ClinicalTrials.gov Info
To read more about the NIAID Phase II Trial of the HIV/AIDS Vaccine, click here. Other new HIV/AIDS trials have also been added to ClinicalTrials.gov in the last 7 days:
click here.
Please send comments or suggestions to ContactUs@aidsinfo.nih.gov
|
